Fingerprint
Dive into the research topics where David Marin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial
Nieto, Y., Banerjee, P., Kaur, I., Basar, R., Li, Y., Daher, M., Rafei, H., Kerbauy, L. N., Kaplan, M., Marin, D., Griffin, L., Barnett, M., Bassett, R., Uprety, N., Shrestha, R., Silva, F. R., Islam, S., Ganesh, C., Borneo, Z. & Ramdial, J. & 16 others, , Jun 2025, In: Nature medicine. 31, 6, p. 1987-1993 7 p.Research output: Contribution to journal › Article › peer-review
33 Link opens in a new tab Scopus citations -
Correction to: Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial (Nature Medicine, (2025), 31, 6, (1987-1993), 10.1038/s41591-025-03640-8)
Nieto, Y., Banerjee, P., Kaur, I., Basar, R., Li, Y., Daher, M., Rafei, H., Kerbauy, L. N., Kaplan, M., Marin, D., Griffin, L., Barnett, M., Bassett, R., Uprety, N., Shrestha, R., Silva, F. R., Islam, S., Ganesh, C., Borneo, Z. & Ramdial, J. & 16 others, , Aug 2025, In: Nature medicine. 31, 8, p. 2816 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access1 Link opens in a new tab Scopus citations -
CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells
Rafei, H., Basar, R., Acharya, S., Hsu, Y. S., Liu, P., Zhang, D., Bohn, T., Liang, Q., Mohanty, V., Upadhyay, R., Li, P., Phadatare, P., Dede, M., Xiong, D., Fan, H., Jones, C. M., Kunz, S., Daher, M., Nunez Cortes, A. K. & Shanley, M. & 38 others, , Jul 24 2025, In: Nature. 643, 8073, p. 1076-1086 11 p.Research output: Contribution to journal › Article › peer-review
Open Access21 Link opens in a new tab Scopus citations -
Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single center
Oran, B., Thall, P., Alousi, A., Al-Atrash, G., Mehta, R., Marin, D., Kebriaei, P., Popat, U., Bassett, R., Bashir, Q., Im, J., Olson, A., Jewell, J., Smallbone, P., Shpall, E. & Champlin, R., Jul 24 2025, In: Haematologica. 111, 1, p. 149-157 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
TP53-mutant variant allele frequency and cytogenetics determine prognostic groups in MDS/AML for transplantation
Lontos, K., Saliba, R. M., Kanagal-Shamanna, R., Özcan, G., Ramdial, J., Chen, G., Kadia, T., Short, N. J., Daver, N. G., Kantarjian, H., Marin, D., Kebriaei, P., Popat, U., Champlin, R., Shpall, E. & Oran, B., Jun 10 2025, In: Blood Advances. 9, 11, p. 2845-2854 10 p.Research output: Contribution to journal › Article › peer-review
Open Access16 Link opens in a new tab Scopus citations